Admedus Adopts the Medidata Clinical Cloud® in Vaccine Study


Applied Clinical Trials

Admedus adopts the Medidata Clinical Cloud® to bring greater speed and efficiency to it’s genital herpes therapeutic vaccine study.

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that Australian-based specialist healthcare company Admedus is using its Medidata Clinical Cloud® platform in its clinical development of a therapeutic vaccine for genital herpes.


Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.